CRISPR-Cas9-directed gene therapy for spinocerebellar ataxia type 1
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_1c1e012d0ca4434c99e39a5e9c36790f | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Mihai Miclăuș |e author |
| 700 | 1 | 0 | |a Gabriel Balmus |e author |
| 245 | 0 | 0 | |a CRISPR-Cas9-directed gene therapy for spinocerebellar ataxia type 1 |
| 260 | |b Elsevier, |c 2024-12-01T00:00:00Z. | ||
| 500 | |a 2162-2531 | ||
| 500 | |a 10.1016/j.omtn.2024.102377 | ||
| 546 | |a EN | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Molecular Therapy: Nucleic Acids, Vol 35, Iss 4, Pp 102377- (2024) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2162253124002646 | |
| 787 | 0 | |n https://doaj.org/toc/2162-2531 | |
| 856 | 4 | 1 | |u https://doaj.org/article/1c1e012d0ca4434c99e39a5e9c36790f |z Connect to this object online. |